GPT Healthcare has reported strong financial results for Q2 of fiscal year 2024-25, with significant increases in operating cash flow and quarterly profit after tax, reaching Rs 14.82 crore. Despite a positive trend in earnings per share, MarketsMojo has issued a 'Hold' recommendation for the company's stocks, citing concerns over the sustainability of rising non-operating income. Overall, the company shows potential for further growth, encouraging investors to maintain their positions.